Linoleate (sodium) [822-17-3]

Référence HY-W011398-1g

Conditionnement : 1g

Marque : MedChemExpress


Description

Linoleate sodium is an orally active IL8 regulator via the JNK and NF-κB pathway. Linoleate sodium can change the composition of fatty acids and the production of metabolites in cells. Linoleate sodium has anti-inflammatory, immune-regulating, and tumor cell growth-affecting activities[1][2][3][4][5][6][7][8][9].

IC50 & Target[1][2][3][4][5][6][7][8][9]

IL-8

 

In Vitro

Linoleate (0.125-1.0 mM, 24 h (for viability test)) sodium increases viability of hepatocytes and regulates TG accumulation in goose primary hepatocytes[1].
Linoleate (100-1000 μM, 9 h) sodium combined with palmitate (500 μM) significantly inhibits IL8 (mRNA and protein) production in Huh7 and HepG2 cells, below that of palmitate alone[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Real Time qPCR[1]

Cell Line: goose primary hepatocytes
Concentration: 0.125, 0.25, 0.5, 1.0 mM
Incubation Time: 24 h
Result: Increased PLIN mRNA and reduced PPARγ mRNA.
Increased mRNA expression of PPARα and CPT-1.
Increased FoxO1 mRNA expression.
Increased MTP mRNA.
Significantly elevated DGAT2 mRNA.
In Vivo

Linoleate (in the form of high-linoleate safflower oil, 10% (w/w), p.o., dietary, 4 weeks) sodium preserves cardiolipin and attenuates mitochondrial dysfunction in the failing rat heart[3].
Linoleate (in the form of a diet containing 15% (w/w) safflower oil; p.o., through diet) sodium reduces the induction of fatty acid synthetase activity in rat liver[4].
Linoleate (in the form of linoleate-enriched safflower oil, 100 ppm, dietary) sodium increases arachidonic acid (20:4n-6) levels in the serum of mice with antigen-induced antibodies and allergic reactions[5].
Linoleate (in the form of linoleate-enriched safflower oil, corresponding to an 18:2n-6/18:3n-3 ratio of 127; dietary) sodium attenuates gastric mucosal damage induced by ethanol, ischemia/reperfusion, and water immersion stress in a rat experimental gastric ulcer model[6].
Linoleate sodium (1 mg/mouse; ip; 1 time) significantly increases the median survival of mice inoculated with EAT cells from 18 days to 48 days, and completely inhibited tumor growth in more than 40% of mice[7].
Linoleate (in the form of linoleate-rich safflower oil, 10% of the semi-purified diet; fed) sodium makes ICR mice more sensitive to pentobarbital, as manifested by a shorter onset of anesthetic effect and a longer duration of anesthetic[8].
Linoleate (in the form of linoleate-rich safflower oil corresponding to an 18:2n-6/18:3n-3 ratio of less than 0.1; fed) can reduce urine protein levels, plasma urea nitrogen levels, glomerular crescent formation, and fibrinoid necrosis in rats with crescent-type anti-glomerular basement membrane nephritis, while increasing the proportion of arachidonic acid (20:4n-6) in glomerular phospholipids[9].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male lean SHHF rats; spontaneously hypertensive heart failure model[3]
Dosage: High-linoleate safflower oil (HLSO), 10% (w/w)
Administration: ad libitum for 4 weeks
Result: Preserved L4CL and total CL to 90% of non-failing levels.
Attenuated 17-22% decreases in state 3 mitochondrial respiration.
Increased left ventricular fractional shortening significantly, and decreased plasma insulin levels.
Augmented the production of several eicosanoid species in serum compared with the control and lard groups.
Masse moléculaire

302.43

Formule

C18H31NaO2

CAS No.
Appearance

Solid

Color

White to light yellow

SMILES

CCCCC/C=C\C/C=C\CCCCCCCC(O[Na])=O

Livraison

Room temperature in continental US; may vary elsewhere.

Stockage

-20°C, stored under nitrogen, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture)

Solvant et solubilité
In Vitro: 

Ethanol : 4 mg/mL (13.23 mM; ultrasonic and warming and heat to 60°C)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.3066 mL 16.5328 mL 33.0655 mL
5 mM 0.6613 mL 3.3066 mL 6.6131 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Calculateur de molarité

  • Calculateur de dilution

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Pureté et documentation
Références